News|Events|February 8, 2024
2024 Rare Disease Summit - 3/19-21
2024 Rare Disease Summit
March 19-21, 2024 | Philadelphia, PA
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Novo Nordisk Submits NDA to FDA for CagriSema
2
The End of the Rebate Era? What HR Leaders and Pharmacy Consultants Need to Know About Biosimilars
3
Roundup: Harbor BioMed Announces Collaboration and License Agreement with Bristol Myers, Squibb, VYNE Therapeutics Enters Merger Agreement with Yarrow Bioscience
4
Pfizer’s Stock Reacts to Decreases in 2026 Revenue Projections in Full-Year 2026 Guidance Release
5